ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Picks Duke To Lead caBIG’s Knowledge Center For Clinical Trials.

July 3, 2008

In Brief: Top Priority: Keep Rauscher; Pay Raise Bill No Moving; Miller, Holland Head AACR, ASCO

May 21, 1976

NIH Plans Consensus Conference On Ovarian Cancer April 5-7

January 28, 1994

In Brief: Issell To Retire As Hawaii Center Director; M.D. Anderson honors LeMaistre, Faculty

November 8, 1996

NCI Progress: Biomarker Labratories Funded To Develop Early Detection Methods

October 22, 1999

DCBD Board Okays Recompetition Of Human Tissue Network

June 30, 1989